To reduce ADR-related morbidity and mortality, several computational attempts to identification potential ADRs have been made, including: I) generating various drug-related profiling (e.g., chemical profiling, cellular response profiling) to predict ADRs at different levels.
CTM focus on the metabolic disease related phenotype, then explores particular signaling pathway characterized by molecular targets or transcriptional events through biochemical or cellular readouts of cellular profiling assays, further to identify their susceptibility genes and enable patients to achieve a personalized medicines treatment.
The follow-up of specific subsets in PACMAN2 will give us the opportunity to identify new pharmacogenetic targets using proteomic and cellular profiling strategies and to validate these in the PACMAN cohort.
In our study, we investigated whether cellular responses of drug combinations can be modeled quantitatively by the cellular profiling of response to individual drugs.
In conclusion, blood transcript profiling has earned its place in the molecular and cellular profiling armamentarium used to study the human immune system.
The simple method for predicting cooperative drug effects confirms the potential predictive ability based only on the quantitative cellular profiling of response to individual drugs.
Indeed, profiling gene transcripts in blood has earned its place in the molecular and cellular profiling approaches used to analyse the immune response in patients with a wide range of diseases in humans [ 17].
Furthermore, the coupling of RNAi with cellular profiling technologies will provide opportunities to streamline drug discovery significantly.
Over-expression of the miRNAs miR-1 and miR-124, for example, shifted cellular expression profiles to those of muscle and brain, respectively [2], with apparent targeting to sequences of only seven and six nucleotides, respectively, in the 3' UTRs of the mRNAs.
To further investigate the observation that Wnt1 induces amplification of the mammary myoepithelial compartment, we characterized the cellular response profile to Wnt1 expression using both β-catenin IHC and a β-catenin/TCF-responsive reporter strain, Axin2NLSlacZ.
